Cancer pharmacogenomics, adoption by oncologists and patient benefit

Personalized Medicine
Lynn G DresslerHoward L McLeod

Abstract

The study aim was to understand physician experience and factors influencing the adoption of cancer pharmacogenomic (caPGx) testing by oncologists practicing in academic and nonacademic settings. Anonymous paper surveys were distributed to oncologists practicing in North Carolina (USA). Although 98% of oncologists see promise in utilizing PGx tests in their practice, few were comfortable with their knowledge (33%) or interpreting test results (37%). At one site, the survey was not distributed due to clinician unfamiliarity with the term 'pharmacogenomics'. Compared with oncologists in academia, community oncologists were more likely to order the new Oncotype Dx™ test for colon cancer (33% vs 0; p = 0.0071), more likely to indicate future use of caPGx tests (94 vs 75%; p = 0.012) and less likely to have never ordered a caPGx test (2 vs 35%%; p < 0.001). Nearly every oncologist was interested in additional PGx education. A critical need exists to disseminate accurate and updated caPGx information to oncologists practicing in both academic and nonacademic settings.

References

Nov 14, 2003·Journal of Managed Care Pharmacy : JMCP·Woodie M Zachry, Edward P Armstrong
Jan 16, 2004·The Medical Journal of Australia·Michael B BartonLizbeth M Kenny
May 3, 2005·Pharmacogenetics and Genomics·Sharon J Gardiner, Evan J Begg
Nov 30, 2005·The Pharmacogenomics Journal·A WoelderinkE Rodriguez-Cerezo
Dec 16, 2005·Pharmacogenomics·Anja RogauschWolfgang Himmel
Sep 19, 2006·Studies in History and Philosophy of Biological and Biomedical Sciences·Adam M Hedgecoe
Oct 24, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lyndsay HarrisUNKNOWN American Society of Clinical Oncology
Dec 15, 2007·Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·Michael MrazekDavid Mrazek
Apr 1, 2008·Community Genetics·Susan B TrinidadWylie Burke
Feb 11, 2009·Public Health Genomics·D GurwitzD Ibarreta
Nov 7, 2009·Pharmacogenomics·Maha KadafourJaekyu Shin
Jan 27, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alberto Bardelli, Salvatore Siena
Mar 12, 2010·American Journal of Pharmaceutical Education·John E MurphyAlan McKay
May 28, 2010·The New England Journal of Medicine·W Gregory FeeroFrancis S Collins
Aug 4, 2010·Nurse Education Today·Crystal H Dodson, Lynne P Lewallen
Feb 11, 2011·Nature·Eric D GreenUNKNOWN National Human Genome Research Institute
Apr 20, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric Van CutsemFortunato Ciardiello
Jun 3, 2011·The Oncologist·Maarten J DeenenJan H M Schellens
Jun 7, 2011·The New England Journal of Medicine·Paul B ChapmanUNKNOWN BRIM-3 Study Group
Jun 10, 2011·American Journal of Pharmaceutical Education·Kristen B McCulloughWayne T Nicholson
Jul 21, 2011·Genetic Testing and Molecular Biomarkers·Susanne B HagaJulianne M O'Daniel
Jan 27, 2012·Clinical Pharmacology and Therapeutics·E J StanekF W Frueh
Apr 26, 2012·The Oncologist·Daniel L HertzWilliam J Irvin
Jan 19, 2013·Pharmacogenomics·Simon de DenusBarbara Vadnais
Feb 9, 2013·Genetic Testing and Molecular Biomarkers·Christina G SelkirkPeter J Hulick
Mar 6, 2013·American Journal of Pharmaceutical Education·Christine M FormeaJoanna L Stollings
Jan 1, 2012·Personalized Medicine·Mary W RoedererHoward McLeod
Sep 1, 2011·Personalized Medicine·Crystal Dodson, Marcia Van Riper

❮ Previous
Next ❯

Citations

Jan 12, 2016·Drug Metabolism and Personalized Therapy·Xandra García-GonzálezLuis A López-Fernández
Mar 27, 2020·Journal of Multidisciplinary Healthcare·Suhaib MuflihKarem H Alzoubi
Jun 10, 2021·Pharmacogenomics and Personalized Medicine·Suhaib MuflihYousef S Khader

❮ Previous
Next ❯

Software Mentioned

SAS
PGx

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Human Genetics
C N HERNDON
Maanedsskrift for praktisk lægegerning og social Medicin
K H BACKER
© 2022 Meta ULC. All rights reserved